Electroencephalogram (EEG) monitoring techniques for neonatal hypoxia-ischemia (HI) are evolving over time, and the specific type of EEG utilized could influence seizure diagnosis and management. We examined whether the type of EEG performed affected seizure treatment decisions (e.g., the choice and number of antiseizure drugs [ASDs]) in therapeutic hypothermia-treated neonates with HI from 2007 to 2015 in the Johns Hopkins Hospital Neonatal Intensive Care Unit. During this period, 3 different EEG monitoring protocols were utilized: Period 1 (2007-2009), single, brief conventional EEG (1 h duration) at a variable time during therapeutic hypothermia treatment, i.e., ordered when a seizure was suspected; Period 2 (2009-2013), single, brief conventional EEG followed by amplitude-integrated EEG for the duration of therapeutic hypothermia treatment and another brief conventional EEG after rewarming; and Period 3 (2014-2015), continuous video-EEG (cEEG) for the duration of therapeutic hypothermia treatment (72 h) plus for an additional 12 h during and after rewarming. One hundred and sixty-two newborns were included in this retrospective cohort study. As a function of the type and duration of EEG monitoring, we assessed the risk (likelihood) of receiving no ASD, at least 1 ASD, or ≥2 ASDs. We found that the risk of a neonate being prescribed an ASD was 46% less during Period 3 (cEEG) than during Period 1 (brief conventional EEG only) (95% CI 6-69%, p = 0.03). After adjusting for initial EEG and MRI results, compared with Period 1, there was a 38% lower risk of receiving an ASD during Period 2 (95% CI: 9-58%, p = 0.02) and a 67% lower risk during Period 3 (95% CI: 23-86%, p = 0.01). The risk ratio of receiving ≥2 ASDs was not significantly different across the 3 periods. In conclusion, in addition to the higher sensitivity and specificity of continuous video-EEG monitoring, fewer infants are prescribed an ASD when undergoing continuous forms of EEG monitoring (aEEG or cEEG) than those receiving conventional EEG. We recommend that use of continuous video-EEG be considered whenever possible, both to treat seizures more specifically and to avoid overtreatment.

Keywords:
Electroencephalography, Neonatal seizure, Amplitude-integrated electroencephalogram, Hypoxia-ischemia, Therapeutic hypothermia, Antiseizure drug
1.
Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG: Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013;1:CD003311.
2.
Harris MN, Carey WA, Ellsworth MA, Haas LR, Hartman TK, Lang TR, et al: Perceptions and practices of therapeutic hypothermia in American neonatal intensive care units. Am J Perinatol 2014;31:15-20.
3.
Wassink G, Gunn ER, Drury PP, Bennet L, Gunn AJ: The mechanisms and treatment of asphyxial encephalopathy. Front Neurosci 2014;8:40.
4.
Low E, Boylan GB, Mathieson SR, Murray DM, Korotchikova I, Stevenson NJ, et al: Cooling and seizure burden in term neonates: an observational study. Arch Dis Child Fetal Neonatal Ed 2012;97:F267-F272.
5.
Glass HC, Wusthoff CJ, Shellhaas RA, Tsuchida TN, Bonifacio SL, Cordeiro M, et al: Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. Neurology 2014;82:1239-1244.
6.
Shah DK, Mackay MT, Lavery S, Watson S, Harvey AS, Zempel J, et al: Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. Pediatrics 2008;121:1146-1154.
7.
Shellhaas RA, Soaita AI, Clancy RR: Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics 2007;120:770-777.
8.
Rennie JM, Chorley G, Boylan GB, Pressler R, Nguyen Y, Hooper R: Non-expert use of the cerebral function monitor for neonatal seizure detection. Arch Dis Child Fetal Neonatal Ed 2004;89:F37-F40.
9.
Shellhaas RA, Chang T, Tsuchida T, Scher MS, Riviello JJ, Abend NS, et al: The American Clinical Neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol 2011;28:611-617.
10.
Booth D, Evans DJ: Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 2004;4:CD004218.
11.
Slaughter LA, Patel AD, Slaughter JL: Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol 2013;28:351-364.
12.
Blume HK, Garrison MM, Christakis DA: Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol 2009;24:148-154.
13.
Boylan GB, Rennie JM, Chorley G, Pressler RM, Fox GF, Farrer K, et al: Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology 2004;62:486-488.
14.
Kilbride RD, Costello DJ, Chiappa KH: How seizure detection by continuous electroencephalographic monitoring affects the prescribing of antiepileptic medications. Arch Neurol 2009;66:723-728.
15.
Wietstock SO, Bonifacio SL, McCulloch CE, Kuzniewicz MW, Glass HC: Neonatal neurocritical care service is associated with decreased administration of seizure medication. J Child Neurol 2015;30:1135-1141.
16.
Appendino JP, McNamara PJ, Keyzers M, Stephens D, Hahn CD: The impact of amplitude-integrated electroencephalography on NICU practice. Can J Neurol Sci 2012;39:355-360.
17.
Shellhaas RA, Barks AK: Impact of amplitude-integrated electroencephalograms on clinical care for neonates with seizures. Pediatr Neurol 2012;46:32-35.
18.
Murray DM, Boylan GB, Ali I, Ryan CA, Murphy BP, Connolly S: Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008;93:F187-F191.
19.
Scher MS, Alvin J, Gaus L, Minnigh B, Painter MJ: Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol 2003;28:277-280.
20.
Nagarajan L, Ghosh S, Palumbo L: Ictal electroencephalograms in neonatal seizures: characteristics and associations. Pediatr Neurol 2011;45:11-16.
21.
Boylan GB, Kharoshankaya L, Wusthoff CJ: Seizures and hypothermia: importance of electroencephalographic monitoring and considerations for treatment. Semin Fetal Neonatal Med 2015;20:103-108.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.